The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,453 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 16,629 | 2,193,795 | SH | SOLE | 2,193,795 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 2,389 | 18,672 | SH | SOLE | 18,672 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 3,451 | 92,000 | SH | SOLE | 92,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,467 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 877 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 458 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047607 | 1,690 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 1,274 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ASPIRA WOMENS HEALTH INC | COM | 04537Y109 | 5,620 | 840,104 | SH | SOLE | 840,104 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 149 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIODESIX INC | COM | 09075X108 | 22,278 | 1,105,083 | SH | SOLE | 1,105,083 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 2,963 | 12,100 | SH | SOLE | 12,100 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | COM | G11196105 | 857 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 2,683 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
BMY CVR RTS 03/31/21 | RIGHT | 110122157 | 763 | 1,105,313 | SH | SOLE | 1,105,313 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 49,276 | 794,386 | SH | SOLE | 794,386 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 1,858 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
CONTINENTAL RESOURCES INC | COM | 212015101 | 629 | 38,600 | SH | SOLE | 38,600 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 1,010 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,308 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 220 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
EQUITRANS MIDSTREAM CORPORATIO | COM | 294600101 | 1,070 | 133,050 | SH | SOLE | 133,050 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 6,368 | 314,143 | SH | SOLE | 314,143 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 720 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 1,235 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,226 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
INARI MEDICAL INC | COM | 45332Y109 | 611 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 352 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 570 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 2,910 | 188,000 | SH | SOLE | 188,000 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 2,147 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 7,687 | 80,200 | SH | SOLE | 80,200 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 384 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
OVINTIV INC | COM | 69047Q102 | 493 | 34,350 | SH | SOLE | 34,350 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | COM | G6855A103 | 2,974 | 170,303 | SH | SOLE | 170,303 | 0 | 0 | ||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 433 | 3,800 | SH | SOLE | 3,800 | 0 | 0 | ||
PROGENITY INC | COM | 74319F107 | 1,328 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROGYNY INC | COM | 74340E103 | 636 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 10,535 | 58,644 | SH | SOLE | 58,644 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203101 | 1,596 | 826,899 | SH | SOLE | 826,899 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 1,239 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 780 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 553 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 2,732 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,051 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 537 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | ||
YIELD10 BIOSCIENCE INC | COM | 98585k102 | 110 | 18,952 | SH | SOLE | 18,952 | 0 | 0 |